UnitedHealthcare History: A Remarkable Transformation From 2023 to 2026
Published: September 2, 2026
Updated: September 2, 2026
Category: U.S. Healthcare, Business & Finance
When people hear the name UnitedHealthcare, they often think first about health insurance.
But from 2023 through 2026, the story became much bigger than insurance cards and monthly premiums.
The business continued to grow at an enormous scale, with UnitedHealth Group’s revenue reaching hundreds of billions of dollars. At the same time, the company faced a very different challenge: how to turn that enormous revenue base into sustainable profits while medical costs, government-program changes, technology spending and the 2024 Change Healthcare cyberattack put pressure on the business.
The numbers tell a fascinating story.
Revenue rose from about $371.6 billion in 2023 to $447.6 billion in 2025. Yet net earnings moved in the opposite direction, falling from $23.1 billion in 2023 to $12.8 billion in 2025.
Then 2026 brought an early sign of improvement.
For the first six months of 2026, UnitedHealth Group reported about $223.8 billion in revenue and $17.0 billion in earnings from operations. Second-quarter operating earnings were $8.0 billion, compared with $5.2 billion in the same quarter of 2025.
This chapter looks at that journey through 25 data tables, followed by a plain-English profit-and-loss analysis.
Table 1 — Consolidated Revenue, 2023–2026
| Year / Period | Revenue |
|---|---|
| 2023 | $371.622 billion |
| 2024 | $400.278 billion |
| 2025 | $447.567 billion |
| 2026 H1 | $223.753 billion |
Revenue continued to climb through 2025. The 2026 figure represents the first six months of the year, not a full-year result.
Table 2 — Net Earnings
| Year / Period | Net Earnings |
|---|---|
| 2023 | $23.144 billion |
| 2024 | $15.242 billion |
| 2025 | $12.807 billion |
| 2026 H1 | $12.151 billion |
The contrast is important: revenue kept growing while reported net earnings fell sharply between 2023 and 2025.
| Year / Period | Earnings |
|---|---|
| 2023 | $22.381 billion |
| 2024 | $14.405 billion |
| 2025 | $12.056 billion |
| 2026 H1 | $11.764 billion |
This measure is particularly useful for understanding the earnings available to UnitedHealth Group common shareholders.
Table 4 — Earnings From Operations
| Year / Period | Operating Earnings |
|---|---|
| 2023 | $32.358 billion |
| 2024 | $32.287 billion |
| 2025 | $18.964 billion |
| 2026 H1 | $16.981 billion |
The biggest deterioration came in 2025, when operating earnings dropped dramatically despite another year of revenue growth.
Table 5 — Consolidated Operating Margin
| Year / Period | Operating Margin |
|---|---|
| 2023 | 8.7% |
| 2024 | 8.1% |
| 2025 | 4.2% |
| 2026 Q2 | 7.1% |
The second quarter of 2026 showed a significant improvement from the difficult 2025 period.
| Year / Period | Premium Revenue |
|---|---|
| 2023 | $290.827 billion |
| 2024 | $308.810 billion |
| 2025 | $352.229 billion |
| 2026 H1 | $174.517 billion |
Premium revenue remained the largest source of consolidated revenue.
Table 7 — Medical Costs
| Year / Period | Medical Costs |
|---|---|
| 2023 | $241.894 billion |
| 2024 | $264.185 billion |
| 2025 | $313.995 billion |
| 2026 H1 | $148.847 billion |
Medical costs increased considerably during this period. For an insurer, that matters enormously because every additional dollar spent on medical care can put pressure on the margin left after premiums are collected.
Table 8 — Operating Costs
| Year / Period | Operating Costs |
|---|---|
| 2023 | $54.628 billion |
| 2024 | $53.013 billion |
| 2025 | $59.592 billion |
| 2026 H1 | $29.658 billion |
Operating costs include the broad expenses required to run the company’s businesses. The company also continued investing in technology, infrastructure and other operational improvements.
Table 9 — Cost of Products Sold
| Year / Period | Cost |
|---|---|
| 2023 | $38.770 billion |
| 2024 | $46.694 billion |
| 2025 | $50.655 billion |
| 2026 H1 | $26.198 billion |
The growing scale of pharmacy and healthcare-service operations contributed to the importance of product-related costs.
Table 10 — UnitedHealthcare Revenue
| Year / Period | Revenue |
|---|---|
| 2023 | $281.360 billion |
| 2024 | $298.208 billion |
| 2025 | $344.9 billion |
| 2026 Q2 | $86.0 billion |
The insurance business remained the largest contributor to the group’s overall revenue. In the second quarter of 2026, UnitedHealthcare served approximately 48.5 million people.
Table 11 — UnitedHealthcare Operating Earnings
| Year / Period | Operating Earnings |
|---|---|
| 2023 | $16.415 billion |
| 2024 | $15.584 billion |
| 2025 | $9.425 billion |
| 2026 Q2 | $3.9 billion |
The decline between 2024 and 2025 was substantial. In the second quarter of 2026, however, operating earnings nearly doubled from $2.1 billion in Q2 2025 to $3.9 billion.
Table 12 — UnitedHealthcare Operating Margin
| Period | Operating Margin |
|---|---|
| 2023 | 5.8% |
| 2024 | 5.2% |
| 2025 | 2.7% |
| Q2 2026 | 4.6% |
The margin story is one of the clearest signs of what happened during this period.
The business remained huge, but the amount of operating profit generated from each dollar of revenue became much smaller in 2025. Q2 2026 showed meaningful improvement.
Table 13 — Optum Revenue
| Year / Period | Optum Revenue |
|---|---|
| 2023 | $226.635 billion |
| 2024 | $252.957 billion |
| 2025 | $270.620 billion |
| 2026 H1 | $129.412 billion |
Optum remained an important second engine of the overall company, covering healthcare services, technology and pharmacy-related operations.
Table 14 — Optum Operating Earnings
| Year / Period | Operating Earnings |
|---|---|
| 2023 | $15.943 billion |
| 2024 | $16.703 billion |
| 2025 | $9.539 billion |
| 2026 H1 | Recovery underway |
The 2025 decline reflected pressure across parts of the Optum business and the broader restructuring and operating challenges facing the company.
Table 15 — Optum Health
| Year | Revenue | Operating Earnings |
|---|---|---|
| 2023 | $95.319B | $6.560B |
| 2024 | $105.358B | $7.770B |
| 2025 | — | -$0.278B |
Optum Health experienced one of the most dramatic changes in the period, moving from strong operating earnings in 2024 to a reported operating loss in 2025.
That shift became an important part of the company’s wider profitability story.
Table 16 — Optum Insight
| Year | Revenue | Operating Earnings |
|---|---|---|
| 2023 | $18.932B | $4.268B |
| 2024 | $18.757B | $3.097B |
| 2025 | — | $2.624B |
Optum Insight was heavily affected by the disruption surrounding the February 2024 Change Healthcare cyberattack.
The event was not simply a technology problem. It affected healthcare providers, claims processing, payments and the broader healthcare system.
Table 17 — Optum Rx
| Year | Revenue | Operating Earnings |
|---|---|---|
| 2023 | $116.087B | $5.115B |
| 2024 | $133.231B | $5.836B |
| 2025 | — | $7.193B |
Pharmacy remained one of the stronger parts of the Optum portfolio and continued to make a major contribution to operating earnings.
Table 18 — 2024 Change Healthcare Cyberattack
| Item | 2024 |
|---|---|
| Direct response costs | About $2.2B |
| Interest-free provider loans through Dec. 31 | More than $9B |
| Estimated Optum Insight business disruption | About $867M |
The February 21, 2024 cyberattack against Change Healthcare became one of the defining events of the company’s recent history.
The disruption reached far beyond UnitedHealth Group because Change Healthcare’s systems were deeply connected to the U.S. healthcare payment and claims ecosystem.
Table 19 — 2023 vs. 2024 Financial Picture
| Metric | 2023 | 2024 |
|---|---|---|
| Revenue | $371.6B | $400.3B |
| Operating earnings | $32.4B | $32.3B |
| Net earnings | $23.1B | $15.2B |
| Common-shareholder earnings | $22.4B | $14.4B |
The headline looks strange at first.
Revenue increased by nearly $29 billion, but net earnings fell by almost $8 billion.
That is a powerful reminder that higher sales do not automatically mean higher profits.
Table 20 — 2024 Profit Pressure
| Factor | Financial Effect |
|---|---|
| Change Healthcare cyberattack | Significant disruption and costs |
| Technology and response spending | Higher expenses |
| Medical-cost trends | Margin pressure |
| Revenue growth | Continued |
| Net earnings | Fell significantly |
For ordinary readers, the simplest way to understand 2024 is this:
The company sold more, but keeping the business running became more expensive.
Table 21 — 2025 Profit Pressure
| Metric | 2024 | 2025 | Change |
|---|---|---|---|
| Revenue | $400.3B | $447.6B | +12% |
| Operating earnings | $32.3B | $19.0B | -41% |
| Net earnings | $15.2B | $12.8B | -16% |
| Common-shareholder earnings | $14.4B | $12.1B | -16% |
The company reported record-level revenue in 2025, but profitability was significantly weaker.
UnitedHealth Group said full-year operating earnings included a $2.8 billion charge related to cyberattack-related activities, divestitures and business exits, restructuring, loss-contract assessments, real-estate rationalization and workforce reductions.
Table 22 — UnitedHealthcare 2025 Performance
| Metric | 2024 | 2025 |
|---|---|---|
| Revenue | $298.2B | $344.9B |
| Operating earnings | $15.6B | $9.4B |
| Operating margin | 5.2% | 2.7% |
| People served | — | 49.8M |
UnitedHealthcare’s revenue increased strongly in 2025, but its operating margin dropped sharply.
The company attributed the pressure primarily to Medicare funding reductions, Inflation Reduction Act impacts and elevated medical-cost trends.
Table 23 — 2026 First-Half Revenue
| Metric | H1 2025 | H1 2026 |
|---|---|---|
| Revenue | $221.2B | $223.8B |
| Premiums | $174.4B | $174.5B |
| Products | $26.6B | $27.1B |
| Services | $18.0B | $19.8B |
| Investment/other | $2.1B | $2.4B |
Revenue was broadly stable in the first half of 2026, but the profitability picture improved.
Table 24 — 2026 First-Half Profit
| Metric | H1 2025 | H1 2026 |
|---|---|---|
| Operating earnings | $14.3B | $17.0B |
| Net earnings | $10.0B | $12.2B |
| Common-shareholder earnings | $9.7B | $11.8B |
| Diluted EPS | $10.61 | $12.94 |
This was one of the most encouraging signs in the early 2026 results.
The company generated substantially more operating and net income than in the first half of 2025.
Table 25 — Q2 2026 Recovery
| Metric | Q2 2025 | Q2 2026 |
|---|---|---|
| Revenue | $111.6B | $112.0B |
| Operating earnings | $5.2B | $8.0B |
| Net margin | 3.1% | 4.9% |
| UnitedHealthcare operating earnings | $2.1B | $3.9B |
| UnitedHealthcare operating margin | 2.4% | 4.6% |
| Medical care ratio | 89.4% | 86.7% |
The second quarter of 2026 provided a much clearer recovery signal.
UnitedHealth Group reported $112.0 billion of revenue and $8.0 billion of earnings from operations. Its medical care ratio improved to 86.7% from 89.4% a year earlier.
Profit and Loss Analysis: What Really Happened From 2023 to 2026?
2023: A Strong Starting Point
2023 was the strongest year in this four-year story from a profit perspective.
Revenue was approximately $371.6 billion, while net earnings reached approximately $23.1 billion.
Operating earnings were about $32.4 billion.
The business entered 2024 with enormous scale and strong profitability.
2024: Revenue Rose, But the Story Changed
At first glance, 2024 looked positive.
Revenue climbed above $400 billion.
But the bottom line told another story.
Net earnings fell from $23.1 billion to $15.2 billion.
The Change Healthcare cyberattack became a major reason.
The February 2024 attack disrupted healthcare transactions across the country. UnitedHealth Group incurred direct response costs and provided substantial financial support to healthcare providers dealing with the disruption.
This created an unusual situation:
More revenue did not translate into more profit.
2025: The Biggest Profitability Test
2025 was even more difficult.
Revenue increased approximately 12% to $447.6 billion.
That sounds like excellent growth.
But earnings from operations fell from about $32.3 billion to $19.0 billion.
Net earnings fell to approximately $12.8 billion.
UnitedHealthcare’s operating margin dropped to 2.7%, compared with 5.2% in 2024.
The company was dealing with several pressures at once.
Medical costs were elevated.
Government-program economics were changing.
Medicare-related funding and policy changes affected the business.
The company also undertook restructuring, business exits and other actions designed to simplify operations.
This is where the difference between revenue growth and profitable growth became impossible to ignore.
2026: Is the Business Finally Turning the Corner?
The first half of 2026 offered a more encouraging picture.
Through June 30, UnitedHealth Group reported:
- $223.8 billion in revenue
- $17.0 billion in earnings from operations
- $12.2 billion in net earnings
- $11.8 billion attributable to common shareholders
- $20.0 billion in operating cash flow for the first six months
The second quarter was particularly notable.
Operating earnings increased from $5.2 billion in Q2 2025 to $8.0 billion in Q2 2026.
The medical care ratio improved from 89.4% to 86.7%.
UnitedHealthcare’s operating margin improved from 2.4% to 4.6%.
That does not mean the problems are over.
But it does suggest that management’s efforts around pricing, benefit design, medical-cost management and operating discipline were beginning to show results.
What Happened to UnitedHealthcare’s Profit Margin?
This is perhaps the most important question for investors and ordinary readers.
Imagine a business collecting $100 from customers.
If it spends $90 providing services and another $7 running the business, only $3 remains as operating profit.
That is essentially what a margin tells us.
The company had enormous revenue throughout this period, but small changes in medical costs could have a major effect on earnings.
That is why the decline in UnitedHealthcare’s operating margin from 5.2% in 2024 to 2.7% in 2025 mattered so much.
By Q2 2026, the margin had recovered to 4.6%.
UnitedHealthcare vs. Optum
Another important part of this history is the relationship between the two major sides of UnitedHealth Group.
UnitedHealthcare is primarily the health-benefits and insurance business.
Optum operates across healthcare services, technology, pharmacy and related areas.
That diversification has become increasingly important.
When insurance margins are under pressure, other parts of the business can provide additional sources of earnings.
But diversification does not eliminate risk.
Optum also faced major challenges during the Change Healthcare disruption and subsequent restructuring.
The Change Healthcare Lesson
The 2024 cyberattack demonstrated something that many consumers may not realize.
Modern healthcare depends on enormous technology networks.
A health insurer is not simply an insurance company.
Claims, payments, pharmacies, doctors, hospitals, employers and government programs all depend on digital systems communicating with each other.
When one major part of that network stops working, the consequences can spread quickly.
For UnitedHealth Group, the incident became both a financial problem and an operational challenge.
It also highlighted the importance of cybersecurity across the U.S. healthcare system.
What Families May Have Felt
Behind these billions of dollars are ordinary people.
Families were dealing with questions such as:
- How much will my health insurance cost?
- What is my deductible?
- Is my doctor still in-network?
- How much will my prescription cost?
- Will Medicare coverage change?
- Why does a medical bill take so long to process?
- Why did my prior authorization change?
- Can I afford the care I need?
The financial statements do not answer all of those questions.
But they help explain why healthcare companies pay such close attention to medical costs, pricing, benefit design and government reimbursement.
What Investors Should Take From 2023–2026
The biggest lesson is simple:
Revenue alone does not tell the whole story.
UnitedHealth Group grew revenue from approximately $371.6 billion in 2023 to $447.6 billion in 2025.
Yet net earnings fell.
That means investors needed to watch more than sales.
The important numbers included:
- Medical care ratio
- Operating margin
- Medical costs
- Government-program economics
- Optum profitability
- Cash flow
- Restructuring charges
- Cybersecurity costs
- Membership trends
- Future pricing
The second quarter of 2026 provided evidence that some of these pressure points were beginning to improve.
2023–2026: The Big Picture
The four-year story can be summarized in four stages.
2023 — Strong Profitability
The company entered the period with strong revenue and earnings.
2024 — Disruption
The Change Healthcare cyberattack created significant operational and financial pressure.
2025 — Profit Squeeze
Revenue reached another record level, but operating earnings and margins dropped sharply.
2026 — Early Recovery
The first half of 2026 showed improving operating earnings, while Q2 showed better medical-cost performance and stronger margins.
Final Analysis
UnitedHealthcare’s history from 2023 through 2026 is not simply a story about getting bigger.
It is a story about how difficult it can be to remain profitable when a healthcare company reaches enormous scale.
The company continued to generate hundreds of billions of dollars in annual revenue.
But higher revenue came alongside higher medical costs, government-program changes, technology expenses, cybersecurity challenges and restructuring.
The biggest warning sign came in 2025.
Revenue rose to about $447.6 billion, yet operating earnings fell to approximately $19.0 billion and net earnings fell to about $12.8 billion.
Then came the first signs of improvement in 2026.
By June 30, 2026, operating earnings for the first six months had reached approximately $17.0 billion, compared with $14.3 billion in the same period of 2025.
And Q2 2026 operating earnings reached $8.0 billion, compared with $5.2 billion a year earlier.
So the most accurate conclusion is neither “everything is fine” nor “the company is in decline.”
The better description is:
UnitedHealth Group entered 2026 in the middle of a major financial and operational reset, with early evidence that profitability was beginning to recover.
For consumers, the important question remains whether these changes eventually lead to a simpler and more affordable healthcare experience.
For investors, the key question is whether improving margins can continue without sacrificing long-term membership, healthcare quality or customer trust.
And for the U.S. healthcare system, the larger lesson is clear: when a company operates at this scale, its financial decisions can affect not only shareholders, but also patients, doctors, hospitals, pharmacies and millions of American families.
Data Note
Annual figures for 2023–2025 are based on UnitedHealth Group’s reported financial statements. 2026 is not a completed fiscal year in this article. The 2026 figures are reported results through June 30, 2026, with quarterly figures identified separately.